Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immune response

Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immune response

US Patent 11583582 · Granted Feb 21, 2023

Estimated economic value: $607,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody molecules to LAG-3 and uses thereof2025
Combined preparations for the treatment of cancer2025
Combined preparations for the treatment of cancer or infection2023
Anti-LAG-3 antibodies2023
Combined preparations for the treatment of cancer or infection2021
Combined preparations for the treatment of cancer or infection2020
Combined preparations for the treatment of cancer2020
Antibody molecules to LAG-3 and uses thereof2020
Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immun2019
Antibody molecules to LAG-3 and uses thereof2018
Use of recombinant LAG-3 or the derivatives thereof for eliciting monocyte immun2017
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevent2016